Concerto's clinical trial, ENS-002 for Atopic Dermatitis in Adults, is now recruiting.More information
SolutionsPortfolio ENS-002 For Atopic DermatitisCB-002 For Calm, Balanced SkinENS-003 For Vaginal Yeast Infections
Technology
Contact
Ecology Unleashed

Our best-in-class products channel symbioses among microbes.

Because we design our products based on a deep understanding of microbial ecology, the microbes in our products synergize with each other—and with the other microbes that they encounter in the real world—to achieve high performance.
Our Portfolio

Our portfolio of microbe-based products addresses high unmet needs across human health.

ENS-002Clinical Testing

Atopic Dermatitis

ENS-002 pacifies S. aureus virulence as a candidate therapeutic for atopic dermatitis.

Learn More About ENS-002
CB-002Real-world Testing

Calm, Balanced Skin

CB-002 is a rich ferment of skin-calming metabolites produced by a beneficial microbe.

Learn More About CB-002
ENS-003kChip-based Discovery

Recurrent Vaginal Yeast Infection

ENS-003 inhibits C. albicans virulence—seeding Concerto’s understanding of how the vaginal microbiome maintains a healthy balance.

Learn More About ENS-003

We welcome partners to accelerate advancement of our existing products or co-discover something new.

Partner with Us
Concerto Product Pipeline
Concerto Product Pipeline
Concerto Product Pipeline
Partner with us

Companies are stronger together.

Concerto’s partners gain access to top-performing, differentiated products that add value to their portfolios. Partner with us to co-develop one of our existing assets. Inquire about the list of ingredient candidates we have waiting in the wings. Or propose a new product concept to co-discover together.

Harness microbial ecology with Concerto to develop new, transformative products. 

Partner With Us

Microbes, like humans, are stronger together than they ever could be alone.
Visit Us

750 Main Street

Cambridge, MA 02139

concerto-biosciences@concertobioinfo@concertobio.com
© 2025 Concerto Biosciences, Inc. All rights reserved.